LIFR and liver cancer: Consistently, LIFR overexpression in the PLC/PRF/5 human liver cancer cell line led to downregulation of IKKα/β phosphorylation and upregulation of IκBα protein levels, and these effects were abolished by knockdown of SHP1 (Fig. 4d).